Joe Bonaccorso
2023
In 2023, Joe Bonaccorso earned a total compensation of $2.1M as Chief Commercial Officer at Verrica Pharmaceuticals, a 113% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,600 |
|---|---|
| Option Awards | $514,593 |
| Salary | $444,000 |
| Stock Awards | $947,500 |
| Other | $13,779 |
| Total | $2,097,472 |
Bonaccorso received $947.5K in stock awards, accounting for 45% of the total pay in 2023.
Bonaccorso also received $177.6K in non-equity incentive plan, $514.6K in option awards, $444K in salary and $13.8K in other compensation.
Rankings
In 2023, Joe Bonaccorso's compensation ranked 486th out of 2,790 executives tracked by ExecPay. In other words, Bonaccorso earned more than 82.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 486 out of 2,790 | 83rd |
Division Manufacturing | 279 out of 1,530 | 82nd |
Major group Chemicals And Allied Products | 193 out of 869 | 78th |
Industry group Drugs | 190 out of 832 | 77th |
Industry Pharmaceutical Preparations | 120 out of 597 | 80th |
Source: SEC filing on April 19, 2024.
Bonaccorso's colleagues
We found two more compensation records of executives who worked with Joe Bonaccorso at Verrica Pharmaceuticals in 2023.